Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05920356
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-05-23
Brief Title:
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIBC Nonsquamous Non-Small Cell Lung Cancers CodeBreaK 202
Sponsor:
Amgen
Organization:
Amgen
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer NSCLC |